DJIA 18,126.12 -36.87 -0.20%
NASDAQ 5,097.98 -8.62 -0.17%
S&P 500 2,120.79 -2.69 -0.13%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

43.16 0.66 (1.55%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

SGEN $43.16 1.55%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $42.36
Previous Close $42.50
Daily Range $41.86 - $43.57
52-Week Range $30.05 - $44.95
Market Cap $5.4B
P/E Ratio -64.39
Dividend (Yield) $0.00 (0.0%)
Volume 970,601
Average Daily Volume 1,217,284
Current FY EPS -$0.76

Sector

Healthcare

Industry

Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website: http://www.seattlegenetics.com/

News & Commentary

Is This Why the Street Keeps Doubting Gilead Sciences, Inc.?

Gilead Sciences looks like a screaming buy right now based on its fundamentals. But the Street apparently doesn't think so. Here's why.

Seattle Genetics Larger Than S&P 500 Component Tenet Healthcare

Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate Program

Seattle Genetics Announces Clinical Data Presentations from Multiple Antibody-Drug Conjugate Programs

4 Big Biotech Companies to Sell Now

Otonomy, Renren And Other Names To Watch Heading Into Next Week

Insiders keep on buying Macerich Co and Seattle Genetics

Trade-Ideas: Seattle Genetics (SGEN) Is Today's Post-Market Leader Stock

4 Momentem Stocks Breaking Out and Poised to Move Higher

First Week of July 17th Options Trading For Seattle Genetics (SGEN)

Insiders new buys : ZU, SGEN, MAC, SHLD, TBRA

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

Seattle Genetics (SGEN) in Focus: Stock Up 8.1% - Tale of the Tape

See More SGEN News...

SGEN's Top Competitors

SGEN $43.16 (1.55%)
Current stock: SGEN
AMGN $157.35 (-1.93%)
Current stock: AMGN
GILD $112.85 (0.35%)
Current stock: GILD
BIIB $400.10 (-0.70%)
Current stock: BIIB